isocarboxazid has been researched along with Jaundice in 2 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Jaundice: A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, WC | 1 |
| Hargreaves, T | 1 |
2 other studies available for isocarboxazid and Jaundice
| Article | Year |
|---|---|
A neglected modality in psychiatric treatment--the monoamine oxidase inhibitors.
Topics: Depression; Humans; Hypertension; Iproniazid; Isocarboxazid; Jaundice; Mental Disorders; Monoamine O | 1975 |
The effect of monoamine oxidase inhibitors on conjugation.
Topics: Animals; Bilirubin; Endoplasmic Reticulum; Glucosyltransferases; Glucuronates; In Vitro Techniques; | 1968 |